Natural history of insect ir, g allergy: Relationship of severity of sym oms of initial sting anaphylaxis to re-sting rea ions

Similar documents
Outcomes of Allergy to Insect Stings in Children, with and without Venom Immunotherapy

CONCLUSIONS: For the primary end point in the total population, there were no significant differences between treatments. There were small, but statis

Insect sting allergy with negative venom skin test responses

Hymenoptera Venom Allergy. David F. Graft, M.D.

Bee Venom Hypersensitivity and Its Management: Patients Perception of Venom Desensitisation

Hymenoptera sting challenge of 348 patients: Relation to subsequent field stings

Factors affecting the prognosis of Honey Bee sting reaction

Stinging insect allergy

Insect Sting Anaphylaxis

University of Groningen. Hymenoptera venom allergy Vos, Byrthe

SPECIAL CONSIDERATIONS ON ANAPHYLAXIS IN LATIN AMERICA

INSTRUCTIONS AND DOSAGE SCHEDULE FOR ALLERGENIC EXTRACTS HYMENOPTERA VENOM PRODUCTS

Allergic Reactions and Envenomations. Chapter 16

Myth: Prior Episodes Predict Future Reactions REALITY: No predictable pattern Severity depends on: Sensitivity of the individual Dose of the allergen

Insect allergy PHILLIP L. LIEBERMAN, MD

Recognition & Management of Anaphylaxis in the Community. S. Shahzad Mustafa, MD, FAAAAI

Single venom-based immunotherapy effectively protects patients with double positive tests to honey bee and Vespula venom

EPIPEN INSERVICE Emergency Administration of Epinephrine for the Basic EMT. Michael J. Calice MD, FACEP St. Mary Mercy Hospital

Urticaria Moderate Allergic Reaction Mild signs/symptoms with any of following: Dyspnea, possibly with wheezes Angioneurotic edema Systemic, not local

Advisor. Bugging Out While stinging insects may have. The Asthma. enter. November 2008

The efficiency of immunotherapy to the subjects with allergy to bee venom and its influence in pollen allergy

UNIVERSITY OF ZAGREB SCHOOL OF MEDICINE. Plan of the course. Basics of Pediatric Allergy. Academic year 2015/2016. Mirjana Turkalj

Terms What is Anaphylaxis? Causes Signs & Symptoms Management Education Pictures Citations. Anaphylaxis; LBodak

Epidemiological Review of Insect Sting Allergy in Naval Aviation: Current Policy and Real-World Practices

Anaphylaxis ASCIA Education Resources Information for health professionals

The Diagnosis and Management of Anaphylaxis

Allergic reactions, ranging from mild allergic

Managing Allergies and Anaphylaxis at School EPI-PEN TRAINING FOR SCHOOL PERSONNEL

Assessing the Relative Risks of Subcutaneous and Sublingual Allergen Immunotherapy

New Test ANNOUNCEMENT

Mosquito Allergy in Children: Clinical features and limitation of commercially-available diagnostic tests

Hymenoptera Venom Immunotherapy and Field Stings R Lang, T Hawranek

7/25/2016. Use of Epinephrine in the Community. Knowledge Amongst Paramedics. Knowledge Amongst Paramedics survey of 3479 paramedics

Anaphylaxis: Treatment in the Community

Bee Sting Allergy. What You Need to Know

Allergy Immunotherapy in the Primary Care Setting

ANAPHYLAXIS IN ANESTHESIA

Concept paper on a Guideline for allergen products development in moderate to low-sized study populations

Which Factors Might Enhance Safety of Immunotherapy in Your Clinic?

Allergic reactions to insect stings: Results from a national survey of 10,000 junior high school children in Israel

Venom immunotherapy improves healthrelated quality of life in patients allergic to yellow jacket venom

P O S S I B L E A N A P H Y L A X I S T O M O S Q U I T O B I T E

Urticaria and Angioedema. Allergy and Immunology Awareness Program

Immunologic Mechanisms of Tissue Damage. (Immuopathology)

Munich and Hamburg, Germany

Chapter 8. Learning Objectives. Learning Objectives 9/11/2012. Anaphylaxis. List symptoms of anaphylactic shock

Monitoring of peanut-allergic patients with peanut-specific IgE

Case 1: HPI. Case 1: PMHx + SHx. Case 1: PMHx + SHx. Case 1: Salient features of Examination. Case 2: Diagnosis and Management. Immunology Meeting

ANAPHYLAXIS EMET 2015

An Insight into Allergy and Allergen Immunotherapy Co-morbidities of allergic disease

West Houston Allergy & Asthma, P.A.

IMMUNOTHERAPY IN ALLERGIC RHINITIS

Policy for the Treatment of Anaphylaxis in Adults and Children

Food and drug reactions and anaphylaxis

Chapter 20 - Immunologic Emergencies

EL DORADO COUNTY EMS AGENCY PREHOSPITAL PROTOCOLS

Managing Allergies and Anaphylaxis at School: Training for School Personnel

Anaphylaxis 5/31/2015

Use of b-blockers during immunotherapy for Hymenoptera venom allergy

Allergy & Anaphylaxis

Mastocytosis and Hymenoptera venom allergy Franziska Ruëff, Marianne Placzek and Bernhard Przybilla

THINGS CLINICIANS AND CONSUMERS SHOULD QUESTION. Developed by the Australasian Society of Clinical Immunology and Allergy

Premedication with antihistamines may enhance efficacy of specific-allergen immunotherapy

Allergy and Immunology Review Corner: Chapter 57 of Middleton s Allergy Principles and Practice, 7 th Edition, edited by N. Franklin Adkinson, et al.

Anaphylaxis School First results of a national multicenter study

Beta-Lactam Use in Penicillin Allergic Patients Clinical Guideline

Allergy Management Policy

Path2220 INTRODUCTION TO HUMAN DISEASE ALLERGY. Dr. Erika Bosio

Allergy School on Investigating allergic effects of environmental exposures. Brindisi, Italy, 2-5 July Venom Allergy. M.

Immunotherapy Vaccines For Allergic Diseases Adrian Young-Yuen Wu, BSc, MBChB, MRCP(UK), FHKCP, FHKAM(Med), DABIM, DABA&I

Transfusion and Allergy: What is it, and what is it not? Prof. Olivier GARRAUD INTS, Paris Université de Lyon/Saint-Etienne France

produced very few allergic reactions so that the method was abandoned. As a result, in order to demonstrate

10/17/2015. Chapter 54. Care of the Patient with an Immune Disorder. Immunocompetence. Immunodeficiency

Omalizumab (Xolair ) ( Genentech, Inc., Novartis Pharmaceuticals Corp.) September Indication

Skin prick testing: Guidelines for GPs

Allergic Reactions and Anaphylaxis. William Mapes, NRP, I/C Chief, Brandon Area Rescue Squad Brandon, VT

RESEARCH Open Access Abstract Background: Methods: Results: Conclusions: Keywords: Background

Who Should Be Premediciated for Contrast-Enhanced Exams?

Determinants of Severe and Fatal Anaphylaxis

Hypersensitivity Reactions and Peanut Component Testing 4/17/ Mayo Foundation for Medical Education and Research. All rights reserved.

Allergy Testing in Childhood: Using Allergen-Specific IgE Tests

ALLERGY TESTING AND TREATMENT

02/06/2013. Goal of program. A few definitions. Objectives of the training. Legal context. Legal context in schools

Allergies & Hypersensitivies

GLORIA Module 4: Allergen Specific Immunotherapy Its safe use: A New Zealand perspective

Allergy overview. Mike Levin Division of Asthma and Allergy Department of Paediatrics University of Cape Town Red Cross Hospital

VACCINE-RELATED ALLERGIC REACTIONS

Survey on practice of venom immunotherapy in France

OBJECTIVES DEFINITION TYPE I HYPERSENSITIVITY TYPES OF HYPERSENSITIVITY ACUTE ALLERGIC REACTION 11/5/2016

Student Health Center

Anaphylaxis/Latex Allergy

Part II of Two Parts. by BUDDY MARTERRE, MD

Corporate Medical Policy Allergy Immunotherapy (Desensitization)

ties It may prevent the onset of asthma; 5- and 10-year follow-up of the preventive allergy treatment study showed that 3 years of AIT with gra

Food Allergies. (Demkin). That is approximately two million kids. That number only represents children, but

Allergy Update. because you depend upon results. Abacus ALS

Workshop summary. Marshall Plaut, MD, Richard T. Sawyer, PhD, and Matthew J. Fenton, PhD. Bethesda, Md

Food allergy in children. nice bulletin. NICE Bulletin Food Allergy in Chlidren.indd 1

A longitudinal study of hymenoptera stings in preschool children

Transcription:

Natural history of insect ir, g allergy: Relationship of severity of sym oms of initial sting anaphylaxis to re-sting rea ions Robert E. Reisman, MD Buffalo, N.Y. To examine the postulate that the nature of the symptoms of initial insect sting anaphylaxis is related to the risk and severity of subsequent sting reactions, the results of field re-stings were analyzed in 220 patients who had had venom anaphylaxis and did not receive venom immunotherapy. The incidence of a reaction after the frst re-sting was 56% in the total group, was more frequent in adults (74%) than in children (40%), and was unrelated to the time interval since the initial sting reaction. When re-sting reactions did occur, the nature of the symptoms was similar to the symptoms of the initial sting reaction. Reactions to repeated re-stings tended to be similar. Overall, more severe reactions to re-stings occurred eventually in 24 patients. These observations confirm the frequent self-limiting course of insect sting allergy, especially in children, and the repetitive nature of specific anaphylactic symptoms, and the observations thus suggest that patients with mild to moderate anaphylactic symptoms probably do not require venom immunotherapy. ( J ALLERGY CIJN IMMUNOL 1992;90:335-9.) Key words: Insect sting anaphylaxis, re-stings, nature of symptoms The availability and subsequent commercial distribution of purified insect venoms in 1979 provided reliable allergens for the diagnosis and treatment of patients with insect sting anaphylaxis. Immunotherapy with insect venoms is almost 100% effective prophylaxis, preventing subsequent sting anaphylaxis. 1 An unexplained finding, initially made in the early studies with venom, was the observation that approximately one half of the patients thought to be allergic to insect stings because of a history of venom anaphylaxis and the presence of venom-specific IgE (positive venom skin tests) did not react when re-stung, in the absence of venom immunotherapy. 2 This dichotomy between clinical sensitivity and immunologic reactivity has been extended in studies of the natural history of insect sting allergy. 3 Schuberth et al. 4 have shown that children with dermal reactions as the sole manifestation of sting anaphylaxis have a very benign course. Subsequent re-stings are usually tolerated with no reaction, and when reactions have occurred, the symptoms From the Allergy Division, Departments of Medicine and Pediatrics, State University of New York at Buffalo School of Medicine, Buffalo. Received for publication Dec. 30, 1991. Revised April 21, 1992. Accepted for publication April 28, 1992. Reprint requests: Robert E. Reisman, MD, Buffalo Medical Group, 295 Essjay Rd., Williamsville, NY 14221. 1 /l/38883 remain mild. In contrast, our studies suggest that patients who have had severe anaphylactic symptoms are likely to continue to have similar severe symptoms after subsequent re-stings? The purpose of this study is to extend these observations of the natural history of insect sting allergy and examine the postulate that the likelihood and severity of re-sting reactions are related to the nature of the symptoms of the initial sting anaphylaxis? Other factors to be considered are the age of the patients and the time interval between repeat stings, The goal is to obtain further insight into the natural history of insect sting allergy and, as a consequence, reassess guidelines for selection of patients requiting venom immunotherapy. PATIENTS IN THE STUDY AND METHODS Records were reviewed of all patients evaluated over the past 10 years because of a history of insect sting anaphylaxis. Patients were included in the study if there was a history of a re-sting after the first episode of sting anaphylaxis in the absence of venom immunotherapy~ Data collected included the age of the patient at the time of the initial sting anaphylaxis, the time mter~'al between the initial sting reaction and subsequenl re-sting, the identification of the responsible stinging insects, the nature of the allergic symptoms, and the effects of any sequential restings. To simplify the analysis, the insect sting reactions were graded as follows: 1, mild, dermal symptoms (urticaria, angioedema) only; II, moderate, dermal reactions and other non-life-threatening symptoms such as mild asthma or dys- 335

336 Reisrnan J ALLERGY CLIN IMMUNOL SEPTEMBER 1992 TABLE I. Summary of relationship of insect sting reaction symptoms to results of subsequent re-sting, in the absence of venom immunotherapy, in the total group of patients Re-sting reaction (No. of patients) No. of I II III Grade patients None Local* Mild Moderate Severe I Mild 102 39 14 38 3 8 II Moderate 61 14 6 5 29 7 III Severe 57 17 6 5 3 26 Total 220 70 26 48 35 41 *A local reaction is defined as swelling extending from the sting site, using peaking in 48 to 72 hours, and lasting 4 to 6 days, in the absence of systemic symptoms. After re-sting 96 patients (44%) had no reaction and 124 (56%) had repeat reactions. pnea; Ill, severe, which included symptoms of shock, hypotension, loss of consciousness, upper airway edema, and/or severe respiratory distress. RESULTS Over the past 12 years approximately 1200 patients have been evaluated because of allergic reactions after insect stings. Two hundred twenty patients were identified who met the following criteria for inclusion in this study: the occurrence of a re-sting after an allergic sting reaction, in the absence of venom immunotherapy. One hundred seventy-five of the 220 patients had the initial sting reaction and subsequent re-sting before their consultation and evaluation. Forty-five patients were evaluated after the initial sting reaction and subsequently had a re-sting. Seventy patients identified the same insect as responsible for the sting reaction and subsequent resting. Seventy-two patients identified the insect as being different, and 128 patients could not identify either one or both insects responsible for the paired stings. The overall results are summarized in Table I. One hundred two patients had initial mild symptoms of sting anaphylaxis. After the next re-sting, 39 had no reaction, 14 had local reactions only, 38 had mild symptoms, 3 had moderate reactions, and 8 patients had severe reactions. Thus 49 (48%) of the patients in this group had a re-sting allergic reaction, 11 of whom had more severe symptoms than the symptoms that occurred with the initial reaction. Sixty-one patients had initial moderate anaphylactic symptoms. After the subsequent re-sting, 14 had no reaction, 6 had local reactions only, 5 had mild symptoms, 29 had moderate symptoms similar to the initial reaction, and 7 patients had more severe symptoms. To summarize this group, 41 patients (67%) had a resting reaction. Fifty-seven patients had initial severe symptoms. After the re-sting 17 patients had no reaction, 6 had local reactions only, 5 had mild reactions, 3 had moderate reactions, and 26 had similar severe reactions. In total, 34 (60%) of this group had re-sting reactions, most were similar to the initial reaction. To summarize, after re-stings 96 patients (44%) had no reaction, and 124 (56%) had repeat reactions. When re-sting reactions did occur, the symptoms tended to be similar to the symptoms of the initial sting reaction. Eighteen of the 163 patients (11%) with initial mild to moderate reactions had more severe resting reactions and are discussed in more detail herein. Seventy patients could identify the same insect as responsible for the initial sting reaction and subsequent re-sting. The overall analysis of this subgroup did not differ significantly from the total group of patients in the study. A similar distribution of patients occurred in the three categories of sting reactions. The incidence and severity of the re-sting reactions were approximately the same as those in the total group (Table II). The relationship of age at the time of the initial sting reaction to the symptoms of the re-sting reaction in the total group is shown on Table III. Patients under the age of 16 years had less likelihood of re-sting reactions, regardless of the severity of the symptoms of the initial reaction. However, the difference in resting reaction rates was only significant (p < 0.001, chi square) for patients with mild anaphylactic symptoms. Sixty-four of 102 patients with mild sting anaphylaxis were under age 16 years, and 38 were over 16 years old. The re-sting reaction rate was 30% in the children and 79% in the adults. Thirty-one patients were less than 16 years old, and 30 were more than 16 years old in a group of patients with moderate reactions. The re-sting reaction rate was 58% in the children and 77% in adults. Seventeen of the 57 patients with severe anaphylaxis were less than 16 years old, and 40 were over 16 years old. The re-sting reaction rates were 47% and 65%, respectively. The relationship of the time interval between the

VOLUME 90 Natural history of insect stir)g alte~gy 337 NUMBER 3, PART 1 TABLE II. Summary of relationship of initial sting reaction symptoms to results of subsequent re-sting in subgroup of patients who identified the same insect as responsible for both stings Re-sting reactions I II lu Total % Grade No. of patients None Mild Moderate Severe reactions 1 Mild 24 14 7 -- 3.~, I q~ II Moderate 17 4 1 12 -- :'6% Ill Severe 29 7 3 3 16 '6~,~ Total initial reactions 25 (36%); total re-sting reactions 45 (64%). TABLE III. Relationship of age at time of initial sting reaction to result of subsequent re-sting Re-sting reaction <16 yr >16 yr Grade No. of patients % Reaction No. of patients % Reaction I Mild 64 30%* 38 79% ti Moderate 31 58% 30 77'k IlI Severe 17 47% 40 65';~ *Difference in re-sting reaction rates between patients under and over 16 years was only significant in groups with mild anaphylactic symptoms (p < 0.001). TABLE IV. Relationship of time interval between initial sting reaction and subsequent re-sting to results of re-sting Time (yr) 0-2 2-5 5-10 ~ 10 No. of re-stings 121 60 23 t6 No. of reactions 70 30 11 I3 (58%) (50%) (48%) i8!%) initial sting reaction and the subsequent re-sting to the occurrence of re-sting anaphylaxis is shown on Table IV. One hundred twenty-one patients reported a resting within 2 years of the initial sting reaction. The re-sting reaction rate was 58%. Sixty patients had restings from 2 to 5 years after the initial reaction, with a 50% re-sting reaction rate. Twenty-three patients had re-stings between 5 and 10 years after the initial sting reaction, with a re-sting reaction rate of 48%. Thirteen reactions occurred in 16 patients (81%) who reported re-stings more than 10 years after their initial sting anaphylaxis. Within this latter group, eight patients had initial mild sting reactions. After the resting, one patient had no reaction, one patient had a mild reaction, one patient had a moderate reaction, and five patients had severe reactions. Two patients who had initial moderate sting reactions had similar reactions after re-stings. Six patients had initial severe sting reactions, and after re-stings, one patient had no reaction, one patient had a moderate reaction, and four patients had severe reactions. As noted in Table I 18 patients had symptoms after a re-sting that were worse than the symptoms that occurred with the initial sting reaction. Eleven patients with initial mild symptoms had worse re-sting reactions. Three patients, one adult and two children had moderate re-sting symptoms, and eight patients, seven adults and one child, had severe symptomsl Seven patients, three adults and four children, had initial moderate symptoms followed by severe re-sting symptoms. Within these groups, three patients under the age of 16 years had initial mild symptoms only and subsequently had moderate or severe re-sting reactions. After the first re-sting after the anaphyiactic reaction, 90 patients had subsequent stings. Sixty patients had reactions from these repeated stings similar to the reaction that occurred after the initial re-sting.

338 Reisman J ALLERGY CLIN IMMUNOL SEPTEMBER 1992 TABLE V. Results of repeated re-stings No of patients with repeated restings 90 Similar response 60 No reaction 29 Same reaction 31 Variable response 30 Similar or less intense reaction followed by no reaction 7 No reaction followed by systemic reaction 20 Similar reaction followed by more severe reaction 3 Twenty-nine of these 60 patients had no reaction from the initial re-sting and no reactions after one to nine repeat stings. Fifteen patients in this group had an initial mild sting reaction, 2 patients had a moderate reaction, and 12 patients had had a severe reaction. Thirty-one patients had reactions from 1 to 10 repeat stings that were of the same intensity as the initial sting and first re-sting anaphylaxis. Eight had had mild initial reactions, 14 had moderate reactions, and 9 had had severe reactions. Thirty patients had a variable response after repeat re-stings. Seven patients had a similar or less intense reaction from the first re-sting and no reaction from subsequent repeat re-stings. Twenty patients had no reaction from one to five re-stings followed by a systemic reaction. Within this group, 3 of the 20 patients had eventual re-sting reactions worse than the original sting reaction. All were adults and had severe re-sting reactions. Two had had initial mild reactions, and one had a moderate reaction. Three other patients had moderate initial and first re-sting reactions and subsequent severe reactions after further stings. Thus 6 of the 90 patients who had repeated re-stings did eventually have reactions that were more severe than the initial and first re-sting reactions. These data are summarized in Table V. DISCUSSION The results of this study support the postulate that the severity of an insect re-sting reaction is related to the severity of the anaphylactic symptoms that occurred with the initial sting reaction. The likelihood of repeat venom anaphylaxis is not related to the severity of the anaphylactic symptoms that occurred with the initial sting reaction except in children with mild anaphylactic symptoms. These children have a lower incidence of repeat sting anaphylaxis. The overall incidence of repeat sting anaphylaxis was 56%, interestingly, very close to that reported in the initial studies that documented the efficacy of venom immunotherapy. 2 The incidence of repeat sting reactions was lower in children (iess than 16 years old) regardless of the severity of the initial sting reaction, but was only significant in patients who had mild initial sting reactions. The lower re-sting reaction rate (30%) in children who have had dermal reactions as the only manifestation of sting anaphylaxis is slightly higher than the 18.6% re-sting reaction rate reported in the most recent update of the Johns Hopkins University experience. 6 In this study the time interval between the initial sting reaction and re-sting was not a factor in predicting subsequent sting reactions, differing from our preliminary report of a small population, which suggested that the longer the interval from the initial sting reaction to the re-sting, the less likelihood exists of a re-sting reaction. 3 It is interesting to note that an extremely high re-sting reaction rate (81%) occurred in those patients who were re-stung more than 10 years after their initial sting reaction. As might be anticipated, only a small number of patients (16) were in this subgroup. The severity of the initial sting reaction symptoms was not a factor. Patients with initial moderate and severe symptoms tended to have similar symptoms after re-stings. Five of the eight patients with initial mild sting reaction symptoms, had severe symptoms after re-stings, differing from the results with the total group. Further experience with more patients is necessary to determine the validity of this seemingly high re-sting reaction rate after the long interval between stings. One of the critiques of this analysis of field re-stings is the identification of the re-sting insect as being the same as that insect that caused the initial reaction. As noted in the "RESULTS" section, 70 of the 220 patients did identify the same insect as that responsible for both the initial and subsequent sting. The yellow jacket was identified by the majority of patients, 43, and the honeybee was identified by 21. The analysis of the re-sting reactions in these 70 patients was essentially similar to the total group (Tables I and II). The similarity of the results in this subgroup of patients to those found in the total group suggest that the analysis of the total patient group is valid. Eighteen of 220 patients had symptoms after the first re-sting that were worse than the symptoms from the initial sting. Of particular note were three patients under the age of 16 years with initial mild symptoms only who subsequently had moderate or severe resting reactions. Current recommendations are not to treat children who have dermal reactions only with venom immunotherapy. Sixty-four children under the age of 16 years had initial mild sting reactions and

VOLUME 90 Natural history of insect sting aite~gy 339 NUMBER 3, PART 1 did not receive venom immunotherapy. These three sting reactions of increased intensity represent an incidence of approximately 5% in the group of patients who might not be candidates for immunotherapy. In their recent review Valentine et al. 6 reported 18 systemic reactions after 196 stings in 86 children who had dermal reactions only after initial stings and were not treated with venom immunotherapy. None of the re-sting reactions were worse than the original sting reaction. Thus although the data reported in this study confirm the Johns Hopkins University experience and support the recommendation that venom immunotherapy is not necessary in children with dermal symptoms as the only manifestation of venom allergy, there are individuals in this group who may have worsening systemic sting reactions. There were 90 patients in whom the effect of repeated re-stings could be observed, again in the absence of venom immunotherapy. Most of these patients (60) had reactions from these repeated stings that were similar to those that occurred after the initial re-sting. Six patients ultimately had more severe reactions after repeated re-stings. In his monograph, Mueller 7 has reviewed other studies addressing the natural history of insect sting allergy. He also found that the nature or severity of the anaphylactic symptoms after a re-sting tend to be similar to the symptoms of the initial sting reaction. Specifically, in a large retrospective study of 400 patients by Woermann, ~ systemic reactions were classified by severity into four categories (I to IV), Symptoms similar to the symptoms of the initial sting reaction occurred after re-stings in 43% (I), 40% (II), 59% (III), and 51% (IV) of patients in each category, respectively. In a small group of 20 untreated adults, Mueller reported a low systemic re-sting reaction rate (20%). In our earlier report of small population groups, 3 the systemic reaction rate in adults was 62% and decreased as the time interval between the initial sting reaction and re-sting increased. In his larger series Woermann 7's reported an overall reaction rate similar to the incidence of re-sting reactions in adults in this study. As noted, in our prior studies of small patient groups, a relationship appeared to exist between the time interval between the initial sting reaction and likelihood of a reaction after the re-sting. Settipane and Chafee 9 also reported a tendency for risk of decreased reactions after a 5-year or greater interval in a small group of patients. On the other hand, in Woermann's 7-s large study the re-sting reaction after 5 years was comparable to the data presented in this study. The results of this study of the natural history of insect sting allergy and the interpretation of other reported data can be summarized as follows: 1. In unselected patients with insect sting anaphylaxis, approximately one half continue t~:~ react to subsequent stings. The prognosis is much better in children with mild symptoms of anaphylaxis than in adults, 2. When reactions do occur, the nature of the symptoms that follow a re-sting is likely to be the same as that which occurred with the first sting reaction. A small number of patients have reactions of increasing severity. 3. After repeated re-stings, most of the patients have reactions similar to those that have [bllowed the first re-sting. A small number of patients eventually have a worse reaction. 4. The likelihood of a re-sting reaction docs not appear to be related to the time interval between the initial sting reaction and re-sting. The major clinical implication of these findings is that patients who have had mild or moderate insect sting reactions may be managed with the availability of emergency medication without venom immunotherapy. This decision requires evaluation of other risk factors, such as coexisting medical problems, concomitant medication use, and patient life-style, along with a full discussion of relevant risk factors with the patient. All patients who have had severe sting reactions and have positive venom skin tests should receive venom immunotherapy, regardless of the time interval since the sting reaction. REFERENCES 1. Valentine MD. Insect venom 'allergy: diagnoses and treatment. J ALLERGY CLIN IMMUNOL 1984;73:299-304. 2. Hunt KI, Valentine MD, Sobotka AK, Benton AW, Amodio F J, Lichtenstein LM. A controlled trial of immunotherapy in insect hypersensitivity. N Engl J Med 1978;299:157-61. 3. Reisman RE. Studies of the natural histo~, of insect sting allergy. Allergy Proc 1989;10:97-101. 4. Schuberth KC, Lichtenstein LM, Kagey-Sobotka A, Szklo M, Kwiterovich KA, Valentine MD. An epidemiol~ic study of insect allergy in children. II. Characteristics of the disease. J Pediatr 1983,102:361-5. 5. Lantner R, Reisman RE. Clinical and immunologic featnres and subsequent course of patients with severe insect sting anaphylaxis. J ALLERGY CLIN IMMUNOL 1989;84:900-6. 6. Valentine MD, Schuberth KC, Kagey-Solx~tka A~ el al. The value of immunotherapy with venom in children with allergy Io insect stings. N Engl J Med 1991;23:1601-3. 7. Mueller UR. Insect sting allergy. New York: Gustav Fischer, Verlag, 1990. 8. Woermann U. Untersuchunger zt~r Naturgeschichte der lnsektenstichallergie. Diss Bern 1985. 9. Settipane GA, Chafee FH. Natural history of at~ergy to Hymenoptera. Clin Allergy 1979:9:385-90.